Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Advanced Solid Tumors × Cetuximab × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 43 Squamous Cell Carcinoma of Head and Neck 20 Carcinoma, Non-Small-Cell Lung 12 Neoplasms 8 Neoplasm Metastasis 8 Head and Neck Neoplasms 8 Lung Neoplasms 7 Colonic Neoplasms 7 Pancreatic Neoplasms 6 Solid Tumors 4 Rectal Neoplasms 4 Colorectal Cancer Metastatic 4 Carcinoma, Squamous Cell 4 Ovarian Neoplasms 3 Gastrointestinal Neoplasms 3 Endometrial Neoplasms 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Mouth Neoplasms 2 Melanoma 2 Locally Recurrent Rectal Cancer 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Carcinoma, Pancreatic Ductal 2 Carcinoma 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1

Interventions

Injections 12 Bevacizumab 7 pembrolizumab 6 Leucovorin 5 Fluorouracil 5 Oxaliplatin 4 Carboplatin 4 Pemetrexed 3 Paclitaxel 3 Docetaxel 3 Capecitabine 3 trifluridine tipiracil drug combination 2 fludarabine 2 Irinotecan 2 Fulvestrant 2 Cyclophosphamide 2 Cisplatin 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 toripalimab 1 tislelizumab 1 sotorasib 1 sacituzumab govitecan 1 palbociclib 1 osimertinib 1 olaparib 1 lazertinib 1 fluzoparib 1 cemiplimab 1 WW Domain-Containing Oxidoreductase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05067283 2026-02-12

KANDLELIT-001

Merck Sharp & Dohme LLC

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡